Close

Ratings by EF Hutton (Tony Butler)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
8/3/2023 Aravive Inc. ARAV Downgrade Hold
(Buy)
1.28
(0.04)
-96.88% Details
7/31/2023 Pyxis Oncology Inc. PYXS New Coverage Buy
(N/A)
2.46
(3.95)
60.57% Details
7/31/2023 Viracta Therapeutics VIRX New Coverage Buy
(N/A)
1.47
(0.64)
-56.46% Details
6/20/2023 CalciMedica CALC New Coverage Buy
(N/A)
5.03
(5.04)
0.2% Details
5/30/2023 Rain Therapeutics RAIN Maintain Buy
(N/A)
 
 
  Details
5/25/2023 Ocean Biomedical, Inc OCEA New Coverage Buy
(N/A)
4.77
(1.49)
-68.76% Details
5/25/2023 Lantern Pharma Inc. LTRN New Coverage Buy
(N/A)
5.15
(5.44)
5.63% Details
5/25/2023 Bionano Genomics BNGO New Coverage Buy
(N/A)
0.67
(0.84)
25.37% Details
5/25/2023 Werewolf Therapeutics Inc. HOWL New Coverage Buy
(N/A)
2.64
(3.25)
23.11% Details
5/25/2023 Agenus Inc. AGEN New Coverage Buy
(N/A)
1.40
(16.00)
1042.86% Details
5/25/2023 Biomea Fusion Inc. BMEA New Coverage Buy
(N/A)
32.74
(5.81)
-82.25% Details
5/25/2023 Sonnet BioTherapeutics SONN New Coverage Buy
(N/A)
0.29
(1.72)
493.1% Details
5/25/2023 Coeptis Therapeutics Holdings, Inc. COEP New Coverage Buy
(N/A)
1.93
(0.31)
-83.94% Details
5/23/2023 Rain Therapeutics RAIN Downgrade Hold
(Buy)
9.93
(1.21)
-87.81% Details
5/16/2023 Apexigen Inc APGN Maintain Buy
(N/A)
 
 
  Details
3/29/2023 IN8bio Inc. INAB New Coverage Buy
(N/A)
1.23
(1.68)
36.59% Details
2/17/2023 CEL-SCI CVM New Coverage Buy
(N/A)
2.82
(1.29)
-54.26% Details
1/6/2023 Fate Therapeutics FATE Maintain Buy
(N/A)
 
 
  Details
1/5/2023 Apexigen Inc APGN New Coverage Buy
(N/A)
0.65
(0.39)
-40% Details
1/5/2023 Atreca Inc. BCEL New Coverage Buy
(N/A)
0.91
(0.09)
-90.11% Details
1/5/2023 GT Biopharma Inc. GTBP New Coverage Hold
(N/A)
1.02
(3.00)
194.12% Details
1/5/2023 TCR2 Therapeutics TCRR New Coverage Hold
(N/A)
1.00
(1.48)
48% Details
1/5/2023 Compugen CGEN New Coverage Buy
(N/A)
0.71
(2.05)
188.73% Details
1/5/2023 Aravive Inc. ARAV New Coverage Buy
(N/A)
1.29
(0.04)
-96.9% Details
1/5/2023 Rain Therapeutics RAIN New Coverage Buy
(N/A)
8.00
(1.21)
-84.88% Details
1/5/2023 G1 Therapeutics GTHX New Coverage Buy
(N/A)
5.73
(2.99)
-47.82% Details
1/5/2023 Adaptimmune Therapeutics plc ADAP New Coverage Buy
(N/A)
1.67
(1.04)
-37.72% Details
1/5/2023 Century Therapeutics IPSC New Coverage Buy
(N/A)
4.97
(3.26)
-34.41% Details
1/5/2023 BioAtla Inc. BCAB New Coverage Buy
(N/A)
8.08
(1.57)
-80.57% Details
1/5/2023 Atara Biotherapeutics ATRA New Coverage Buy
(N/A)
3.28
(0.53)
-83.84% Details
1/5/2023 Merus N.V. MRUS New Coverage Buy
(N/A)
15.62
(57.65)
269.08% Details
1/5/2023 Allogene ALLO New Coverage Buy
(N/A)
5.76
(2.54)
-55.9% Details
1/5/2023 Bicycle Therapeutics BCYC New Coverage Buy
(N/A)
30.00
(24.30)
-19% Details
1/5/2023 CRISPR Therapeutics CRSP New Coverage Buy
(N/A)
41.00
(65.26)
59.17% Details
1/5/2023 Replimune Group REPL New Coverage Buy
(N/A)
26.35
(9.46)
-64.1% Details
1/5/2023 Fate Therapeutics FATE New Coverage Buy
(N/A)
10.17
(3.76)
-63.03% Details